Lantus (Insulin Glargine) and Progesterone HRT Interaction
Clinical guide to the drug interaction between Lantus (insulin glargine) and progesterone hormone replacement therapy, including mechanism, severity, monitoring, and dose adjustment.
Insulin Glargine: Drug Interactions
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
30articles
3topic areas covered
May 26, 2026latest review
Insulin Glargine: Drug Interactions library
Showing 30 of 30 clinical reviews.
Lantus (Insulin Glargine) and Testosterone Interaction: Safety, Risks, and Monitoring
Can you take Lantus with testosterone? Learn about the insulin glargine and testosterone interaction, including effects on blood glucose, polycythemia risk, monitoring protocols, and dose adjustments.
Lantus and Acetaminophen Interaction: What Patients and Clinicians Should Know
A clinical review of the insulin glargine (Lantus) and acetaminophen interaction, covering pharmacodynamic effects, CGM interference, hepatic considerations, monitoring protocols, and patient counseling.
Lantus and Apixaban Interaction: What Patients and Clinicians Need to Know
A detailed clinical review of the insulin glargine (Lantus) and apixaban interaction, covering pharmacokinetic and pharmacodynamic mechanisms, bleeding and hypoglycemia risk, monitoring parameters, and patient counseling points.
Lantus and Atorvastatin Interaction: What You Need to Know
Clinical guide to the insulin glargine (Lantus) and atorvastatin interaction, including mechanism, severity, monitoring parameters, and dose adjustment recommendations.
Lantus and Benzodiazepines Interaction: What Patients and Clinicians Need to Know
A clinician-reviewed guide to the pharmacodynamic interaction between insulin glargine (Lantus) and benzodiazepines, covering mechanism, hypoglycemia risk, monitoring parameters, dose considerations, and patient counseling points.
Lantus and Bupropion Interaction: What Clinicians and Patients Need to Know
A full clinical review of the insulin glargine (Lantus) and bupropion drug interaction, covering mechanism, blood glucose effects, seizure risk, monitoring protocols, and patient counseling.
Lantus and Clopidogrel Interaction: What You Need to Know
Is it safe to take insulin glargine (Lantus) with clopidogrel (Plavix)? A clinical review of the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment guidance.
Lantus and Diphenhydramine Interaction: What You Need to Know
A clinical guide to the interaction between insulin glargine (Lantus) and diphenhydramine (Benadryl), covering mechanism, severity, monitoring, and dose adjustments.
Lantus and Estradiol HRT Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the pharmacodynamic interaction between insulin glargine (Lantus) and estradiol HRT, covering mechanism, blood glucose monitoring, dose adjustment, and patient counseling.
Lantus and Finasteride Interaction: What Prescribers and Patients Should Know
Is it safe to take insulin glargine (Lantus) with finasteride? A clinical review of pharmacokinetic and pharmacodynamic data, drug interaction database ratings, and monitoring recommendations.
Lantus and Gabapentin Interaction: What Patients and Clinicians Need to Know
A clinician-level review of the Lantus (insulin glargine) and gabapentin drug interaction, covering mechanism, hypoglycemia risk, sedation overlap, monitoring parameters, and dose-adjustment guidance with primary literature citations.
Lantus and Hormonal Contraceptives Interaction: What You Need to Know
A clinical guide to the interaction between insulin glargine (Lantus) and hormonal contraceptives, including mechanism, severity, monitoring, and dose adjustment.
Lantus and Levothyroxine Interaction: What You Need to Know
Clinical guide to the insulin glargine (Lantus) and levothyroxine interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling.
Lantus and Metformin Interaction: Safety, Mechanism, and Clinical Monitoring
Evidence-based guide to the insulin glargine (Lantus) and metformin drug interaction, including pharmacodynamic synergy, hypoglycemia risk, dose adjustment protocols, and monitoring guidelines for type 2 diabetes.
Lantus and NSAIDs (Ibuprofen, Naproxen) Interaction
Clinical guide to the insulin glargine and NSAID drug interaction, covering hypoglycemia risk, renal effects, monitoring protocols, and dose adjustment strategies.
Lantus and Opioids (Oxycodone, Hydrocodone, Tramadol) Interaction
Clinical guide to the drug interaction between insulin glargine (Lantus) and opioids including oxycodone, hydrocodone, and tramadol. Covers hypoglycemia risk, monitoring, and dose adjustment.
Lantus and PPIs (Omeprazole, Pantoprazole): Drug Interaction Guide
Clinical review of the interaction between insulin glargine (Lantus) and proton pump inhibitors (omeprazole, pantoprazole), covering mechanism, severity, monitoring, and dose adjustment.
Lantus and Prednisone Interaction: What Happens When You Take Insulin Glargine With a Glucocorticoid
Clinical guide to the insulin glargine (Lantus) and prednisone drug interaction, including mechanism, severity, dose adjustment strategies, monitoring protocols, and patient counseling.
Lantus and Pregabalin Interaction: What Patients and Prescribers Should Know
A clinical guide to the insulin glargine (Lantus) and pregabalin interaction, covering mechanism, severity, monitoring parameters, dose adjustments, and patient counseling.
Lantus and Rivaroxaban Interaction: What Clinicians and Patients Need to Know
Evidence-based review of the insulin glargine (Lantus) and rivaroxaban drug interaction, including mechanism, clinical significance, monitoring parameters, and dose adjustment guidance.
Lantus and Rosuvastatin Interaction: Safety, Monitoring, and Clinical Evidence
Can you take Lantus (insulin glargine) with rosuvastatin? A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment considerations.
Lantus and Sildenafil Interaction: What Patients and Prescribers Need to Know
A clinical guide to the insulin glargine (Lantus) and sildenafil drug interaction, covering mechanism, hypoglycemia risk, blood pressure monitoring, dose adjustment, and patient counseling.
Lantus and Simvastatin Interaction: What Prescribers and Patients Should Know
A clinical guide to the insulin glargine (Lantus) and simvastatin drug interaction, covering mechanism, severity, monitoring protocols, dose adjustments, and patient counseling.
Lantus and SNRIs (Venlafaxine, Duloxetine) Interaction: What Prescribers and Patients Need to Know
A full clinical review of the insulin glargine (Lantus) and SNRI interaction, covering mechanism, blood-glucose effects, monitoring protocols, dose-adjustment guidance, and patient counseling for venlafaxine and duloxetine.
Lantus and SSRIs (Sertraline, Escitalopram): Drug Interaction Guide
Clinical guide to the insulin glargine (Lantus) and SSRI interaction. Covers hypoglycemia risk, monitoring protocols, dose adjustment, and patient counseling for sertraline and escitalopram use with basal insulin.
Lantus and Tadalafil Interaction: What You Need to Know
A clinical guide to the insulin glargine (Lantus) and tadalafil interaction, including hypoglycemia risk, blood pressure effects, monitoring protocols, and dose-adjustment guidance.
Lantus and Trazodone Interaction: What You Need to Know
Clinical guide to the insulin glargine (Lantus) and trazodone drug interaction, including mechanism, severity, monitoring parameters, and dose adjustment recommendations.
Lantus and Warfarin Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the insulin glargine and warfarin drug interaction, covering mechanism, INR monitoring, dose adjustments, and patient safety counseling.
Lantus and Zolpidem Interaction: Safety, Risks, and Clinical Guidance
Can you take Lantus (insulin glargine) with zolpidem? Learn about the pharmacodynamic interaction, hypoglycemia risk during sleep, monitoring protocols, and dose-adjustment guidance backed by FDA labels and clinical evidence.